Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1 (ITHER)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02840058 |
|
Recruitment Status :
Recruiting
First Posted : July 21, 2016
Last Update Posted : August 2, 2021
|
Sponsor:
Centre Hospitalier Universitaire de Besancon
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Besancon
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 2022 |
| Estimated Study Completion Date : | December 2022 |